Case T-12/24: Judgment of the General Court of 2 September 2026 – Ferring Pharmaceuticals v Commission (Medicinal products for human use – Generic medicinal products – Marketing authorisation for the medicinal product for human use Degarelix Accord – degarelix acetate – Lack of bioequivalence study with the reference medicinal product – Article 10(1) and (2) of Directive 2001/83/EC – Manifest error of assessment – Principle of good administration)
62024TA0012 · TA · 2026-09-02 · sector 6